Novel Antiplatelet Therapies for Atherothrombotic Diseases

Antiplatelet therapies are an essential tool to reduce the risk of developing clinically apparent atherothrombotic disease and are a mainstay in the therapy of patients who have established cardiovascular, cerebrovascular, and peripheral artery disease. Strategies to intensify antiplatelet regimens...

Descripción completa

Detalles Bibliográficos
Autores principales: Majithia, Arjun, Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
ATVB in Focus: From Cells to the Clinic: Progress in the Development of Novel Therapeutics for ATVB Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445601/
https://www.ncbi.nlm.nih.gov/pubmed/30760019
http://dx.doi.org/10.1161/ATVBAHA.118.310955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445601/
https://www.ncbi.nlm.nih.gov/pubmed/30760019
http://dx.doi.org/10.1161/ATVBAHA.118.310955

Ejemplares similares